These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34869350)

  • 1. A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma.
    Huo J; Cai J; Guan G; Liu H; Wu L
    Front Cell Dev Biol; 2021; 9():761839. PubMed ID: 34869350
    [No Abstract]   [Full Text] [Related]  

  • 2. A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma.
    Huo J; Fan X; Qi B; Sun P
    Front Genet; 2022; 13():771819. PubMed ID: 35126478
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma.
    Huo J; Cai J; Wu L
    Cancer Med; 2023 Jan; 12(1):898-912. PubMed ID: 35651292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes.
    Wan S; Lei Y; Li M; Wu B
    Hepatol Int; 2022 Feb; 16(1):112-124. PubMed ID: 34449009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer.
    Shang Z; Wang Z; Zhang Y; Liu S
    Transl Cancer Res; 2023 Oct; 12(10):2781-2805. PubMed ID: 37969400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma.
    Zhao Y; Song Q; Xu F; Zhou Y; Zuo X; Zhang Z
    Front Genet; 2022; 13():823443. PubMed ID: 35368686
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis.
    Huo J; Xie W; Fan X; Sun P
    Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma.
    Ren H; Zheng J; Cheng Q; Yang X; Fu Q
    Front Genet; 2022; 13():900713. PubMed ID: 35957699
    [No Abstract]   [Full Text] [Related]  

  • 9. A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma.
    Huo J; Wu L; Zang Y
    Front Mol Biosci; 2020; 7():581354. PubMed ID: 33282911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma.
    Wang Q; Wang B; Ma X; Zhuang H; Xie Z; Tang C; Tan W; Yang L; Shang C; Chen Y
    J Hepatocell Carcinoma; 2023; 10():1-16. PubMed ID: 36647389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma.
    Chen Y; Zhu Y; Dong Y; Li H; Gao C; Zhu G; Mi X; Li C; Xu Y; Wang G; Cai S; Han Y; Xu C; Wang W; Yang S; Ji W
    Front Oncol; 2023; 13():1085188. PubMed ID: 37051536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma.
    Ding J; He X; Luo W; Zhou W; Chen R; Cao G; Chen B; Xiong M
    Front Genet; 2022; 13():801419. PubMed ID: 35140750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients.
    Wang J; Han K; Zhang C; Chen X; Li Y; Zhu L; Luo T
    J Gastrointest Oncol; 2021 Oct; 12(5):2345-2360. PubMed ID: 34790397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma.
    Jiang A; Meng J; Bao Y; Wang A; Gong W; Gan X; Wang J; Bao Y; Wu Z; Lu J; Liu B; Wang L
    Front Oncol; 2021; 11():755212. PubMed ID: 34804944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.
    Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH
    Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of Angiogenesis and Ferroptosis Genes for Predicting the Survival Outcome and Immunotherapy Response of Hepatocellular Carcinoma.
    Wang P; Kong G
    J Hepatocell Carcinoma; 2024; 11():1845-1859. PubMed ID: 39364435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships of Ferroptosis and Pyroptosis-Related Genes with Clinical Prognosis and Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Yu J; Chen Y; Pan X; Wen W
    Oxid Med Cell Longev; 2022; 2022():3713929. PubMed ID: 36246400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
    Fu XW; Song CQ
    Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma.
    Zheng C; Peng Y; Wang H; Wang Y; Liu L; Zhao Q
    Pharmgenomics Pers Med; 2023; 16():39-58. PubMed ID: 36726530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A programmed cell death-related gene signature to predict prognosis and therapeutic responses in liver hepatocellular carcinoma.
    Gu X; Pan J; Li Y; Feng L
    Discov Oncol; 2024 Mar; 15(1):71. PubMed ID: 38466483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.